Metabolix, Inc. (MBLX)
Q2 2012 Earnings Call
July 26, 2012 04:30 p.m. ET
Rick Eno, President & CEO
Joe Hill – CFO
Laurence Alexander – Jefferies
Mike Ritzenthaler -- Piper Jaffray
JinMing Liu -- Ardour Capital
Jeff Osborne -- Stifel Nicolaus
Uu Yang – JPMorgan
Good afternoon, ladies and gentlemen, thank you for standing by. Welcome to the Metabolix Incorporated Second Quarter 2012 Earnings Conference Call. Today
s call is being recorded. At this time, all participants are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session. Instructions will be provided at that time for you to queue up for your questions.
I would like to turn the conference over to Ms. Allison Townsend of ICR. Please go ahead ma
Thank you, and good afternoon, everyone. After the market closed today, Metabolix issued two press releases, the second quarter 2012 financial results press release and the announcement of a letter of intent with Antibióticos to manufacture Mirel Biopolymers. If you have not received a copy of these press releases copies may be found on the website at www.metabolix.com in the Investor Relations section.
In addition, today we have provided several slides to accompany the presentation. These slides are available via webcast on the Metabolix website in conjunction with today
Making the presentation today will be Richard Eno, President and Chief Executive Officer of Metabolix; and Joseph Hill, Chief Financial Officer of the company. They are joined by Oliver Peoples, a co-founder of Metabolix and Chief Scientific Officer.